Abstract
Attention deficit hyperactivity disorder (ADHD) is characterised by the typical behavioural core symptoms of inattentiveness, hyperactivity and impulsiveness. ADHD is a usually chronic health conditions, mostly diagnosed in childhood, creating a significant challenge for youth, their families and professionals who treat it. This disorder requires long-term treatments, including psychotherapeutic and pharmacological interventions, which in some cases may lead to adverse effects. Understanding the mechanism by which ADHD risk factors affect the biochemical processes in the human brain and consequentially the behaviour will help to identify novel targets for the development of therapeutics with less adverse results and better efficacy including higher responder rates. Although inflammatory responses in the brain have been recognised for years as critical in neurodegeneration and behaviour in a number of neurological and psychiatric disorders, their role for the development, treatment and prevention of ADHD has been so far largely overlooked, although historically, ADHD symptoms were initially observed in patients who survived an ONJ infection, i.e. inflammation. In this review, we discuss the interrelationship between different ADHD risk factors and inflammation with respect to the triggered molecular mechanisms and the contribution they are likely to have to this disorder. This paper provides a rationale for future studies on ADHD with an intent to inspiring the development of new agents for a more efficient management of this disorder.
Similar content being viewed by others
References
Aerts N, De Knop K, Leysen J, Ebo D, Bridts C, Weyler J, Stevens W, De Clerck L (2010) Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (in press)
Asghar S, Pasch M (2000) Therapeutic inhibition of the complement system. Y2K update. Front Biosci 5:E63–E81
Atkins C, Oliva AJ, Alonso O, Pearse D, Bramlett H, Dietrich W (2007) Modulation of the cAMP signaling pathway after traumatic brain injury. Exp Neurol 208:145–158
Barbacid M, Lamballe F, Pulido D, Klein R (1991) The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta 1072:115–127
Barnum S (1995) Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6:132–146
Bazan N (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29:263–271
Bergamaschi A, Corsi M, Garnier M (2006) Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells. Cell Signal 18:1679–1684
Bhat N, Zhang P, Lee J, Hogan E (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633–1641
Bonci A, Williams J (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796–803
Bradstreet J, Smith S, Baral M, Rossignol D (2010) Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 15:15–32
Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75:259–269
Choi S, Joe E, Kim S, Jin B (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23:5877–5886
Church DF, Pryor WA (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111–126
Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151
Combs C, Karlo J, Kao S, Landreth G (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179–1188
Conner A, Kissling C, Hodges E, Hünnerkopf R, Clement R, Dudley E, Freitag C, Rösler M, Retz W, Thome J (2008) Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population. Am J Med Genet B Neuropsychiatr Genet 147B:1476–1480
Conrad C, Marshall P, Talent J, Malakowsky C, Choi J, Gracy R (2000) Oxidized proteins in Alzheimer’s plasma. Biochem Biophys Res Commun 275:678–681
Costenbader KH, Karlson EW (2006) Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 15:737–745
Coti Bertrand P, O’Kusky J, Innis S (2006) Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J Nutr 136:1570–1575
Crews F, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115–127
Dai S, Zhou Y, Li W, An J, Li P, Yang N, Chen X, Xiong R, Liu P, Zhao Y, Shen H, Zhu P, Chen J (2010) Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J Neurosci 30:5802–5810
Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I (2009) S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793:1008–1022
Donev R, Kolev M, Millet B, Thome J (2009) Neuronal death in Alzheimer’s disease and therapeutic opportunities. J Cell Mol Med 13:4329–4348
Emmerling M, Watson M, Raby C, Spiegel K (2000) The role of complement in Alzheimer’s disease pathology. Biochim Biophys Acta 1502:158–171
Encinas JM, Manganas L, Enikolopov G (2005) Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep 5:232–238
Fenton W, Dickerson F, Boronow J, Hibbeln J, Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158:2071–2074
Forsberg P, Martin S, Nilsson B, Ekman P, Nilsson U, Engström L (1990) In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways. J Biol Chem 265:2941–2946
Fredriksson A, Archer T (2004) Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res 6:435–456
García-Nogales P, Almeida A, Bolaños J (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J Biol Chem 278:864–874
Gershov D, Kim S, Brot N, Elkon K (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192:1353–1364
Grossfield A, Feller S, Pitman M (2006) A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc Natl Acad Sci USA 103:4888–4893
Hakobyan S, Harris C, van den Berg C, Fernandez-Alonso M, de Jorge E, de Cordoba S, Rivas G, Mangione P, Pepys M, Morgan B (2008) Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J Biol Chem 283:30451–30460
Harper C (1998) The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 57:101–110
Harper C, Matsumoto I (2005) Ethanol and brain damage. Curr Opin Pharmacol 5:73–78
Hill D, D’Souza N, Lee E, Burikhanov R, Deaciuc I, de Villiers W (2002) A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26:74–82
Hofmann M, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath M, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt A (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889–901
Hope B, Nagarkar D, Leonard S, Wise R (2007) Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. J Neurosci 27:1964–1972
Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann H, Waisman A, Kuhlmann C (2010) Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24:1023–1034
Jonakait G (2007) The effects of maternal inflammation on neuronal development: possible mechanisms. Int J Dev Neurosci 25:415–425
Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 53:174–180
Kaur C, Ling E (2008) Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem 15:3068–3080
Kawakita E, Hashimoto M, Shido O (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139:991–997
Kholodenko R, Kholodenko I, Sorokin V, Tolmazova A, Sazonova O, Buzdin A (2007) Anti-apoptotic effect of retinoic acid on retinal progenitor cells mediated by a protein kinase A-dependent mechanism. Cell Res 17:151–162
King V, Huang W, Dyall S, Curran O, Priestley J, Michael-Titus A (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672–4680
Kolev M, Ruseva M, Harris C, Morgan B, Donev R (2009) Implication of complement system and its regulators in Alzheimer’s disease. Curr Neuropharmacol 7:1–8
Kolev M, Tediose T, Sivasankar B, Harris C, Thome J, Morgan B, Donev R (2010) Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration. Pharmacogenomics J 10:12–19
Kostrzewa R, Kostrzewa J, Kostrzewa R, Nowak P, Brus R (2008) Pharmacological models of ADHD. J Neural Transm 115:287–298
Lagace D, Noonan M, Eisch A (2007) Hippocampal neurogenesis: a matter of survival. Am J Psychiatry 164:205
Lasky-Su J, Neale B, Franke B, Anney R, Zhou K, Maller J, Vasquez A, Chen W, Asherson P, Buitelaar J, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades R, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen H, Taylor E, Daly M, Laird N, Lange C, Faraone S (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B:1345–1354
Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Devière J (1995) Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 22:1436–1439
Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Devière J (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49:646–657
Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154–1162
Linnet K, Dalsgaard S, Obel C, Wisborg K, Henriksen T, Rodriguez A, Kotimaa A, Moilanen I, Thomsen P, Olsen J, Jarvelin M (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 160:1028–1040
Liu JS, Zhao ML, Brosnan CF, Lee SC (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057–2066
Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler B, De Caterina R (2006) The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 103:15184–15189
McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteous L, Prince E, Sonuga-Barke E, Warner J, Stevenson J (2007) Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370:1560–1567
McClain C, Cohen D (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349–351
McClain C, Hill D, Song Z, Chawla R, Watson W, Chen T, Barve S (2002) S-adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 27:185–192
Melis M, Camarini R, Ungless M, Bonci A (2002) Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci 22:2074–2082
Mick E, Biederman J, Faraone S, Sayer J, Kleinman S (2002) Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 41:378–385
Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P (2004) Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9:801–810
Miller VM, Lewis DA, Rud KS, Offord KP, Croghan IT, Hurt RD (1998) Plasma nitric oxide before and after smoking cessation with nicotine nasal spray. J Clin Pharmacol 38:22–27
Min S, Moon I, Ko R, Shin H (2001) Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers. Psychopharmacology (Berl) 159:83–88
Misener V, Schachar R, Ickowicz A, Malone M, Roberts W, Tannock R, Kennedy J, Pathare T, Barr C (2004) Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder. Neuropsychobiology 50:231–234
Monje M, Toda H, Palmer T (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760–1765
Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M (2006) The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19:1437–1445
Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, Yasu T, Saito M, Momomura S, Kawakami M (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196:129–135
Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M (1997) Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 79:1538–1541
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952
Osaka H, Mukherjee P, Aisen P, Pasinetti G (1999) Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 73:303–311
Paine T, Neve R, Carlezon WJ (2009) Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 34:2143–2155
Pasinetti G (1996) Inflammatory mechanisms in neurodegeneration and Alzheimer’s disease: the role of the complement system. Neurobiol Aging 17:707–716
Qin L, He J, Hanes R, Pluzarev O, Hong J, Crews F (2008) Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 5:10
Raz R, Gabis L (2009) Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol 51:580–592
Redford EJ, Kapoor R, Smith KJ (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120(Pt 12):2149–2157
Reif A, Rösler M, Freitag C, Schneider M, Eujen A, Kissling C, Wenzler D, Jacob C, Retz-Junginger P, Thome J, Lesch K, Retz W (2007) Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 32:2375–2383
Reif A, Jacob C, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne C, Strobel A, Freitag C, Giegling I, Romanos M, Hartmann A, Rösler M, Renner T, Fallgatter A, Retz W, Ehlis A, Lesch K (2009) Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66:41–50
Retz W, Reif A, Freitag C, Retz-Junginger P, Rösler M (2010) Association of a functional variant of neuronal nitric oxide synthase gene with self-reported impulsiveness, venturesomeness and empathy in male offenders. J Neural Transm 117:321–324
Rezaee F, Rellick S, Piedimonte G, Akers S, O’Leary H, Martin K, Craig M, Gibson L (2010) Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One 5:e9690
Ribasés M, Hervás A, Ramos-Quiroga J, Bosch R, Bielsa A, Gastaminza X, Fernández-Anguiano M, Nogueira M, Gómez-Barros N, Valero S, Gratacòs M, Estivill X, Casas M, Cormand B, Bayés M (2008) Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 63:935–945
Riediger N, Othman R, Suh M, Moghadasian M (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109:668–679
Romanos M, Gerlach M, Warnke A, Schmitt J (2010) Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 64:269–273
Rushforth S, Allison C, Wonnacott S, Shoaib M (2010) Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task. Neurosci Lett 471:114–118
Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS (1999) Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 82:43–47
Schlaepfer I, Clegg H, Corley R, Crowley T, Hewitt J, Hopfer C, Krauter K, Lessem J, Rhee S, Stallings M, Wehner J, Young S, Ehringer M (2007) The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition. Addict Biol 12:200–209
Schmitt J, Romanos M, Schmitt N, Meurer M, Kirch W (2009) Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 301:724–726
Schmitt J, Apfelbacher C, Chen C, Romanos M, Sausenthaler S, Koletzko S, Bauer C, Hoffmann U, Krämer U, Berdel D, von Berg A, Wichmann H, Heinrich J, Group GINIpS (2010) Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 125:404–410
Segman R, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, Darvasi A, Levy S, Goltser T, Weizman A, Galili-Weisstub E (2002) Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry 7:72–74
Sen J, Belli A (2007) S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 85:1373–1380
Sharp S, McQuillin A, Gurling H (2009) Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 57:590–600
Shinawi M, Liu P, Kang S, Shen J, Belmont J, Scott D, Probst F, Craigen W, Graham B, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez D, Kozel B, Sparagana S, Roeder E, McGrew S, Kurczynski T, Allison L, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet A, Cheung S, Lupski J (2009) Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioral problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47:332–341
Shiow L, Paris K, Akana M, Cyster J, Sorensen R, Puck J (2009) Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin Immunol 131:24–30
Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 14:615–619
Silva C, Rio M, Cruz C (1985) Local immunoglobulin synthesis and blood-brain barrier assessment in subacute sclerosing panencephalitis. Eur Neurol 24:128–133
Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470–476
Smith M, Moylan J, Smith J, Li W, Reid M (2007) IFN-gamma does not mimic the catabolic effects of TNF-alpha. Am J Physiol Cell Physiol 293:C1947–C1952
Spector R (1988) Fatty-acid transport through the blood-brain barrier. J Neurochem 50:639–643
Stillwell W, Shaikh S, Zerouga M, Siddiqui R, Wassall S (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 45:559–579
Tai C, Chen C, Lee H, Wang Y, Li T, Mersamm H, Ding S, Wang P (2009) Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism. J Biol Chem 284:32239–32247
Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42:177–185
Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G (2009) Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 66:722–727
Tikka T, Fiebich B, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580–2588
Toga A, Thompson P, Sowell E (2006) Mapping brain maturation. Trends Neurosci 29:148–159
Vincent S (2010) Nitric oxide neurons and neurotransmission. Prog Neurobiol 90:246–255
Wan J, Fu A, Ip F, Ng H, Hugon J, Page G, Wang J, Lai K, Wu Z, Ip N (2010) Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer’s disease. J Neurosci 30:6873–6881
Wang H, Zakhari S, Jung M (2010) Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J Gastroenterol 16:1304–1313
Yan S, Ramasamy R, Naka Y, Schmidt A (2003) Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159–1169
Yan T, McQuillin A, Thapar A, Asherson P, Hunt S, Stanford S, Gurling H (2010) NK1 (TACR1) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD. J Psychopharmacol 24:27–38
Zhou JF, Yan XF, Guo FZ, Sun NY, Qian ZJ, Ding DY (2000) Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci 13:44–55
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Donev, R., Thome, J. Inflammation: good or bad for ADHD?. ADHD Atten Def Hyp Disord 2, 257–266 (2010). https://doi.org/10.1007/s12402-010-0038-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-010-0038-7